Precision Medicine – Its Potential and Questions

Since the Human Genome Project was declared complete in April of 2003, there has been great anticipation of medical treatments tailored to the individual genetic makeup of patients. For you, for patients, for family members…where have most of the advances been made since that time and what ethical questions are arising as this work continues to evolve? Our guests today are two national experts that have been immersed in this work over the past decade: Damon Hostin, CEO of the Precision Medicine Alliance and Amy Lynn McGuire, Director of the Center for Medical Ethics and Health Policy, at Baylor College of Medicine.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *